Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sepsis and cholestasis.

Michael Fuchs1, Arun J Sanyal

  • 1Division of Gastroenterology, Department of Internal Medicine, Virginia Commonwealth University Medical Center, 1200 E Broad Street, PO Box 980341, Richmond, VA 23298-0341, USA.

Clinics in Liver Disease
|February 5, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Effect of Terlipressin on Renal Replacement Therapy in Patients with Hepatorenal Syndrome.

Kidney360·2023
Same author

Reduced metabolic flexibility is a predictor of weight gain among liver transplant recipients.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·2023
Same author

Fibrosis Progression Rate in Biopsy-Proven Nonalcoholic Fatty Liver Disease Among People With Diabetes Versus People Without Diabetes: A Multicenter Study.

Gastroenterology·2023
Same author

Pegbelfermin in Patients With Nonalcoholic Steatohepatitis and Stage 3 Fibrosis (FALCON 1): A Randomized Phase 2b Study.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2023
Same author

Pegbelfermin in Patients With Nonalcoholic Steatohepatitis and Compensated Cirrhosis (FALCON 2): A Randomized Phase 2b Study.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2023
Same author

Noninvasive Assessment of Liver Fibrosis in NAFLD.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2023
Same journal

Metabolic Dysfunction-Associated Steatohepatitis: From Fibrosis-Based Risk Stratification to Emerging Therapeutic Strategies.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease and Viral Hepatitis.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction Associated Steatohepatitis (MASH) in Oceania, Central America, and the Caribbean.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease in Latin America.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease in Africa: From Burden to Action.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease in Asia: Epidemiology, Clinical Features, and Management.

Clinics in liver disease·2026
See all related articles

Sepsis-associated cholestasis, a complication of bacterial infections, involves specific molecular mechanisms. This overview covers its clinical presentation, diagnosis, and treatment.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Molecular Biology

Background:

  • Cholestasis frequently complicates bacterial infections and sepsis.
  • Sepsis-induced liver injury is a significant clinical concern.

Purpose of the Study:

  • To provide a comprehensive overview of sepsis-associated cholestasis.
  • To elucidate the molecular mechanisms, clinical features, and management strategies.

Main Methods:

  • Literature review of molecular mechanisms.
  • Analysis of clinical presentation and diagnostic approaches.
  • Review of current therapeutic interventions.

Main Results:

  • Detailed explanation of molecular pathways contributing to cholestasis in sepsis.

Related Experiment Videos

  • Description of clinical signs including jaundice.
  • Summary of diagnostic tools and treatment options.

    • Conclusions:

    • Sepsis-associated cholestasis requires a thorough understanding of its pathophysiology.
    • Effective management involves timely diagnosis and targeted therapy.